These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 4231080)
1. [Thrombolysis therapy, its use and dosage. I. Theoretical considerations]. Bosseckert H Z Arztl Fortbild (Jena); 1966 Jul; 60(13):777-81. PubMed ID: 4231080 [No Abstract] [Full Text] [Related]
2. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents]. Gross R Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339 [No Abstract] [Full Text] [Related]
3. [Clinical use of fibrinolytic drugs]. Düzenli MA; Ozdemir K; Sökmen A; Karabağ T Anadolu Kardiyol Derg; 2003 Jun; 3(2):162-70. PubMed ID: 12826513 [No Abstract] [Full Text] [Related]
4. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics]. Pelosio L; Marasco A; Puopolo G Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661 [No Abstract] [Full Text] [Related]
6. [Prevention and therapy of thrombosis in the aged]. Crolle G G Gerontol; 1971 Oct; 19(10):718-25. PubMed ID: 5140482 [No Abstract] [Full Text] [Related]
7. A symposium: Thrombosis and antithrombotic therapy--direction for the '90s. April 13-16, 1989, Fort Lauderdale, Florida. Am J Cardiol; 1990 Feb; 65(6):1C-54C. PubMed ID: 2301271 [No Abstract] [Full Text] [Related]
8. Clinical and laboratory experiences with selective thrombolysis. Bookstein JJ Ann Radiol (Paris); 1984; 27(4):322-3. PubMed ID: 6234843 [No Abstract] [Full Text] [Related]
9. Thrombolysis in extremital arteries--indications and methods. Wellander E; Risberg B Ann Chir Gynaecol; 1995; 84(4):341-8. PubMed ID: 8687077 [No Abstract] [Full Text] [Related]
10. [Thrombolytic therapy in the aged (introduction to a round table discussion)]. De Nicola P G Gerontol; 1971 Oct; 19(10):713-7. PubMed ID: 5140481 [No Abstract] [Full Text] [Related]
11. [Clinical pharmacology of drugs used in thromboembolism]. Orzechowska-Juzwenko K Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1663-7. PubMed ID: 6679090 [No Abstract] [Full Text] [Related]
13. [Anticoagulants and platelet active drugs in arterial occlusive disease (author's transl)]. Bollinger A Ther Umsch; 1980 Feb; 37(2):128-31. PubMed ID: 7385080 [No Abstract] [Full Text] [Related]
14. [For and against the anticoagulants--for and against thrombolysis]. Gross R Internist (Berl); 1969 Jan; 10(1):1-2. PubMed ID: 4906436 [No Abstract] [Full Text] [Related]
15. [Recent developments in the field of fibrinolytics and anticoagulants]. Lechner K; Korninger C; Pabinger-Fasching I Internist (Berl); 1984 Feb; 25(2):82-7. PubMed ID: 6368457 [No Abstract] [Full Text] [Related]
17. [Fibrinolysis and thrombolytic therapy under laboratory control]. Osten W Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109 [No Abstract] [Full Text] [Related]
19. Drugs in the treatment of thrombo-embolic diseases--Part II. Bouchier-Hayes D Ir Med J; 1983 Mar; 76(3):155-9. PubMed ID: 6345455 [No Abstract] [Full Text] [Related]